38 C
Vientiane
Monday, April 28, 2025
spot_img
Home Blog Page 51

Appotronics and Valeo announce strategic partnership for next-generation front lighting system

Valeo and Appotronics will collaborate to create new front lighting systems that utilize innovative laser video projection technology.

These innovative solutions will enhance adaptive lighting (ADB) functionalities in vehicles, significantly improving road safety and address drivers’ increasing demands for more comfortable lighting options and entertainment features.

SHANGHAI, April 23, 2025 /PRNewswire/ — Valeo, a world leader in automotive lighting systems and software, together with Appotronics (688007.SH), inventor of ALPD® laser display technology have announced a strategic partnership to offer a new generation of automotive front lighting solutions integrating exclusive Appotronics’ ALL-in-ONE full-color laser headlight system.

Valeo will bring its unique expertise in lighting systems design and electronic control units design, along with unrivaled software capabilities, to integrate Appotronics recognized knowledge in projection systems design based on laser display technologies into new generation front lighting solutions.

Maurizio Martinelli, CEO of Valeo Light Division, stated: “This partnership strengthens Valeo’s global leadership in next-generation lighting, combining safety, adaptability, and an enhanced driving experience. Leveraging our combined expertise in automotive lighting hardware and software, this new partnership reinforces existing technology alliances and reflects a shared ambition to redefine smart automotive lighting.

Yu Xin, Vice President of Appotronics, said: “The Appotronics-Valeo partnership represents a transformative step in smart automotive lighting, combining our complementary strengths to advance next-generation illumination solutions. Together, we’re accelerating innovations that prioritize safety, intelligent adaptability, and personalized driving experiences for the global market.


A smart lighting system for safer and more immersive driving

By combining their expertise, Valeo and Appotronics will offer headlight solutions that provide advanced lighting functions (ADB) to complement traditional lighting functions (LH/HB), thereby improving safety and comfort for drivers and other road users.

Valeo will leverage its integration and software capabilities to integrate Appotronics state of the art ALPD® laser display technology. The front lighting system will offer high-definition information projection onto the ground, as well as outdoor movie projection capabilities—enabling video playback on flat surfaces or dedicated screens outside the vehicle.

ALL-in-ONE: A breakthrough in smart automotive lighting

The ALL-in-ONE system integrates several advanced functions in one compact module: Adaptive Driving Beam (ADB), road surface projection, and in-car cinema capabilities. Its smart system automatically optimizes lighting for different driving scenarios—extending illumination range with high beams on highways, and preventing glare with glare-free beams in urban areas. In addition, the headlight also offers 10-level brightness adjustment, complete with auto-focus, keystone correction, and image scaling capabilities.

The ALL-in-ONE headlight is powered by Appotronics’ proprietary ALPD® semiconductor laser technology, which delivers 10 times the brightness of standard automotive LEDs with 200% greater luminous flux using equivalent DLP chips – all while consuming less energy.

About Valeo

Valeo is a technology company and partner to all automakers and new mobility players worldwide. Valeo innovates to make mobility safer, smarter and more sustainable. Valeo enjoys technological and industrial leadership in electrification, driving assistance systems, reinvention of the interior experience and lighting everywhere. These four areas, vital to the transformation of mobility, are the Group’s growth drivers.

Valeo in figures:  21.5 billion euros in sales in 2024 | 106,100 employees, 28 countries, 155 plants, 64 research and development centers and 19 distribution platforms at February 28, 2025. Valeo is listed on the Paris Stock Exchange

Learn more at www.valeo.com 


Media Contact

Dora Khosrof | +33 7 61 52 82 75
Caroline De Gezelle | + 33 7 62 44 17 85
Jérôme Abribat | + 33 7 64 86 58 20
press-contact.mailbox@valeo.com

Investor Relations
+33 1 40 55 37 93
valeo.corporateaccess.mailbox@valeo.com

About Appotronics

Appotronics is the inventor of the ALPD® laser display technology and one of the first companies to list on the Shanghai Stock Exchange STAR Market. From optics for cinemas, vehicles and home, to AR glasses, Appotronics’ cutting-edge products are designed to meet the evolving needs of consumers and businesses worldwide. Learn more at https://www.appotronics.com/


Media Contact

Song Jingli | +86 186 1017 6043
songjingli@highseador.com

Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

HANGZHOU, China, April 22, 2025 /PRNewswire/ — Zhejiang Doer Biologics Co., Ltd. (“Doer Bio”), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its first-in-class (FIC), tri-specific agonist targeting Fibroblast growth factor 21 receptor (FGF21R), Glucagon receptor (GCGR), and Glucagon-like peptide-1 receptor (GLP-1R) has completed the dosing of the first patient in the Phase 2 study of DR10624 for the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

The Phase 2 study (DR10624-202) is a randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of three dose levels of DR10624 in adult subjects at high risk of liver fibrosis associated with MASLD. Key inclusion criteria include a liver fat content (LFC) ≥ 10%, as measured by Magnetic Resonance Imaging-derived Proton Density Fat Fraction (MRI-PDFF), and liver stiffness (LSM) ≥ 8 Kpa, and < 15 Kpa, assessed via FibroScan®. A total of 96 participants will be enrolled in the study. The primary endpoint of this study is relative percentage change from baseline in LFC, as measured by MRI-PDFF after 12 weeks of treatment.

“DR10624 is a first-in-class long-acting tri-agonist targeting FGF21R, GLP-1R, and glucagon receptor (GCGR). Developed using Doer Bio’s proprietary MultipleBody® platform technology, DR10624 was engineered to exhibit balanced activity for metabolic diseases. In non-clinical studies, DR10624 has shown remarkable, dose-dependent efficacy in liver protection and antihyperlipidemic activity, leading to reductions in steatosis, inflammation, and ballooning, as well as improved NAS scores in B6-Alms1-del mice—a spontaneous MASH model characterized by obesity, hyperglycemia, and dyslipidemia.” said Yanshan Huang, Ph.D., founder and Chief Executive Officer of Doer Bio.

“We’re pleased to announce the dosing of first patient in our Phase 2 study of DR10624 for the treatment of MASLD/MASH. Patients with MASLD face an increased risk of cardiovascular disease and type 2 diabetes, while MASH, a more severe form of MASLD, is a leading cause of liver failure globally. Without effective treatment, MASH can progress to cirrhosis, liver failure, and even hepatocellular carcinoma or death. This DR10624-202 study is designed to determine the optimal dose of DR10624 for the treatment of MASLD/MASH. We are committed to advancing DR10624 as a potential treatment for patients affected by these serious liver diseases”. commented Yongliang Fang, Ph.D., Chief Operating Officer of Doer Bio.

About Doer Bio

Zhejiang Doer Biologics Co., Ltd. (“Doer Bio”) is a clinical stage biopharmaceutical company that focuses on the discovery and development of multi-domain based multi-specific biotherapeutics to address unmet medical need in the field of metabolic diseases and cancers.

Doer Bio has developed multiple proprietary platform technologies, including xLONGylation®, MultipleBody®, AccuBody®, and SMART-VHHBody.

For more information about Doer Bio, please visit www.doerbio.com.

Strong Partnership for Future Momentum! Paper Chain Southeast Asia Expo + WEPACK Southeast Asia 2025 to Launch in Jakarta

SHANGHAI, April 23, 2025 /PRNewswire/ — To further strengthen the upstream and downstream synergistic effects of the paper-making and packaging industrial chains, two major organizers specializing in paper-making and packaging exhibitions – China National Chemical Information Center and RX will co-host the Paper Chain Southeast Asia Expo + WEPACK Southeast Asia 2025 in Jakarta, Indonesia.

The exhibition, to be held from July 29 to 31, 2025, at Indonesia JIEXPO Exhibition Center, will feature over 300 participating enterprises and present a high-quality supply system for the whole Southeast Asian paper-making and packaging industrial chain. Its organizers will deeply explore industry resources from multiple countries such as Indonesia, Vietnam, Malaysia, and Thailand, extensively invite trade visitors from related application industries to attend for consultation, help exhibitors effectively expand more intended customers and promote in-depth cooperation and mutual benefits between Chinese and Southeast Asian paper-making and eco-friendly packaging industries.


With diverse demands in Southeast Asian market driving the development of corrugated packaging market, as well as rapid growth of emerging industries like e-commerce and take-out in addition to traditional commodity and transportation packaging needs, packaging manufacturers have witnessed increasing demands for short-order equipment, corrugated paper processing equipment, folding carton processing equipment, and food container processing equipment, etc. According to research data from authoritative market consulting institutions, the Southeast Asian corrugated packaging market is expected to have a compound annual growth rate of 4% during the 2021-2026 forecast period. 

RX, the organizer of WEPACK Southeast Asia, has keenly captured market development trends, and begun to host the Indonesian Corrugated Folding Carton Manufacturing Summit since 2011. By doing so, it has accumulated extensive resources from industry buyers, media, and associations, and established long-term cooperative relationships with local authoritative institutions such as the Association Corrugated Converting Indonesia (ACCI), Indonesian Packaging Federation (IPF), and Indonesian Pulp & Paper Association (APKI). Such profound market foundation enables WEPACK to precisely link with the Southeast Asian packaging industry and assist exhibitors in quickly expanding local markets.


Upgraded Exhibition to Land in Indonesia

Paper Chain Southeast Asia Expo + WEPACK Southeast Asia 2025 will officially move to Indonesia. As Southeast Asia’s largest economy, Indonesia holds a crucial position in the global packaging industry, demonstrating strong momentum especially in paper packaging, eco-friendly packaging, and intelligent packaging fields. This will provide more potential market opportunities and help expand markets in Southeast Asia and global business at large.

Indonesia offers a massive market with rapid packaging industry growth.

Indonesia is one of Southeast Asia’s largest manufacturing and transportation hubs and one of the world’s fastest-growing emerging markets, with swift economy development featured by a stable annual growth rate of 5% and robust market vitality.

The Indonesian market influences over 600 million consumers in ASEAN. With robust export growth, it is gradually becoming a major player in the international packaging market. In recent years, Indonesia has attracted significant global investment, particularly in electric vehicles, battery manufacturing, logistics, and packaging sectors. At the same time, the booms in e-commerce, take-out, food and beverage, and pharmaceutical industries have driven increased demand for paper packaging, eco-friendly packaging, and intelligent packaging.

Paper Chain Southeast Asia Expo + WEPACK Southeast Asia, in alignment with national strategy, receives vigorous government and industry support.

Paper Chain Southeast Asia Expo + WEPACK Southeast Asia actively responds to the China-ASEAN cooperation strategy. Previous editions had garnered support from industry associations across various countries and regions, including the Asian Corrugated Cases Association (ACCA), Association Corrugated Converting Indonesia (ACCI), Malaysia Printing Association (MPA), Federation of Malaysian Manufacturers (FMM), Philippine Printing Partnership (PPP), Corrugated Box Manufacturers’ Association (CBMA), Malaysian Corrugated Carton Manufacturers’ Association (MACCMA), Lanka Corrugated Cartons Manufacturers Association (LCCMA), Hong Kong Corrugated Paper Manufacturers’ Association (HKCPMA), Vietnam Packaging Association (VINPAS) and Vietnam Printing Association (VPA), etc., continuously raising the exhibition’s international influence.


Additionally, Paper Chain Southeast Asia Expo + WEPACK Southeast Asia has received policy support from Guangdong Province’s “Guangdong Trade Global” campaign, with participating enterprises from Guangdong eligible for allowances, further reducing exhibitors’ costs for overseas market expansion.

WEPACK Southeast Asia will be co-located and held in conjunction with Paper Chain Southeast Asia Expo, creating a whole industrial chain display platform from paper-making to packaging and end application:

  • Upstream: Paper-making, pulp, eco-friendly materials
  • Midstream: Packaging equipment, printing technologies, intelligent packaging
  • Downstream: Packaging applications in food, beverage, pharmaceutical, e-commerce industries, etc.

This integrated exhibition model will greatly improve connection efficiency between upstream and downstream industrial chain enterprises, while helping exhibitors precisely expand into the Southeast Asian market.

Strong partnership for joint efforts in creating a whole industrial chain packaging gala in Southeast Asia

In 2025, Paper Chain Southeast Asia Expo + WEPACK Southeast Asia reached a strategic cooperation agreement with Paper Chain Indonesia to launch in conjunction at the same location, collaboratively creating the largest and most comprehensive whole industrial chain specialized exhibition gala covering the paper-making technology, packaging processing, and packaging application in the Southeast Asian region.

Paper Chain Indonesia, as the only specialized exhibition in Indonesia focusing on pulping, paper-making, and eco-friendly packaging, has received strong support from government departments and business associations in Indonesia, Vietnam, China, Thailand, and other countries. The exhibition is co-organized by China National Chemical Information Center (CNCIC) and Indonesian Pulp and Paper Association (IPPA), who signed a memorandum of deep cooperation mechanism in the ChinaIndonesia paper-making and packaging industry in 2023. IPPA annually organizes over 30 local Indonesian front-line paper-making and packaging manufacturers to participate in the exhibition.

Paper Chain Southeast Asia Expo & WEPACK Southeast Asia 2025 looks forward to your participation, to jointly expand into the Indonesian and Southeast Asian packaging market!

ChangAn Automobile Embraces Innovation with “Together for a Smarter World” Theme at Auto Shanghai 2025

SHANGHAI, April 23, 2025 /PRNewswire/ — ChangAn Automobile (“ChangAn” or “the Company”), an intelligent low-carbon mobility technology company, officially unveiled its Together for a Smarter World theme at Auto Shanghai 2025. At the event, the spotlight was on the Company’s three major strategies, namely, its Mission of Shangri-La for new energy, Dubhe 2.0 Plan for intelligence, and its Vast Ocean Plan for global expansion, marking the beginning of a new chapter in advanced, green automobile technology.


As part of its ongoing transformation, ChangAn has made major technological strides through its three core strategies. As part of the Mission of Shangri-La, the Company developed the Golden Shield solid-state battery and a full range of new energy products, including the BlueCore 3.0 powertrain and the industry’s first PREV, combining PHEV and REEV technologies. The Dubhe 2.0 Plan has advanced intelligent systems such as the Intelligent TS Drive, Intelligent TY Cockpit, and Intelligent TH Chassis. The Vast Ocean Plan has expanded ChangAn’s global footprint, particularly in Europe.


With years of investment in R&D, ChangAn Automobile has built a strong foundation in new energy and intelligent mobility, driving the rollout of next-generation smart vehicles. At Auto Shanghai 2025, ChangAn unveiled three flagship digital intelligent models—CHANG-AN Q07, DEEPAL S09, and AVATR 06—a new generation of smart solutions from its three core brands that highlights the company’s leadership in advancing and popularizing smart mobility—each exemplifying the company’s leadership in digital-intelligent automotive development. In a global first, the company revealed a future mobility lineup that includes flying cars, humanoid robots, robot dogs, wheeled robots, and smart exoskeletons. These innovations offered a striking vision of tomorrow’s transportation landscape and ChangAn’s role in shaping it.

ChangAn also brought together over 500 domestic and international media outlets and more than 600 global partners to witness the digital-intelligent achievements of its three major brands at this year’s Auto Shanghai. Through immersive brand pavilion experiences, cutting-edge technology showcases, and a dedicated global media briefing, ChangAn delivered a compelling demonstration of its innovation capabilities—marking the start of a dynamic, tech-powered journey with global resonance.

“In 2017, ChangAn Automobile fully implemented its business venture, advancing three major strategies—the Mission of Shangri-La, Dubhe 2.0 Plan, and Vast Ocean Plan—to resolutely transform into an intelligent, low-carbon mobility technology company. “said Mr. Zhu Huarong, Chairman of ChangAn Automobile. Since then, ChangAn Automobile has consistently embraced innovation and pursued a high-end, intelligent, and green development path.

As the global industrial landscape evolves at an accelerating pace, ChangAn is committed to exploring new possibilities for future mobility in collaboration with the broader industry. The Company believes the power of science and technology will drive and illuminate this new era of human mobility.

About ChangAn Automobile
ChangAn is an intelligent low-carbon mobility technology company. Its product lineup includes passenger vehicles, pick-ups, and light commercial vehicles. Powered by innovation and industrial upgrading, the Company is committed to advancing sustainable mobility and becoming a global industry leader. In April 2025, ChangAn released its 2024 ESG Report—the 17th since 2008. The company has supported initiatives such as disaster relief in Southeast Asia, the Luban Workshop in Peru, and desertification control in Saudi Arabia. Its commitment to sustainability earned it a place on the “Top 100 ESG-listed Companies in China” for the first time.

 

Samsung Biologics reports first quarter 2025 financial results

  • Recorded Q1’25 consolidated revenue of KRW 1.3 trillion
  • Recorded Q1’25 consolidated operating profit of KRW 486.7 billion
  • Company expected to maintain steady growth momentum in 2025 driven by enhanced operational efficiency and diverse service offerings

INCHEON, South Korea, April 23, 2025 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2025.

“We sustained solid momentum in the first quarter, supported by the efficient operations across all our plants and continued partnerships with our clients,” said John Rim, CEO and President of Samsung Biologics. “The launch of Plant 5 and our dedicated antibody-drug conjugate (ADC) facility marks another milestone in expanding our capacity to cater to diverse client demands. We remain committed to delivering long-term value for clients and shareholders through strategic investments in technology while continuously offering competitive advantages with our development and manufacturing capabilities.”

FIRST QUARTER 2025 RESULTS

Samsung Biologics reported consolidated revenue of KRW 1.3 trillion in the first quarter of 2025, mainly driven by the stable ramp-up of Plant 4 while maintaining the full utilization of Plants 1 through 3, alongside favorable impact of foreign exchange rates. The company maintains its full-year earnings guidance of 20–25% revenue growth.

On a standalone basis, Samsung Biologics posted revenue of KRW 999.5 billion and an operating profit of KRW 430.1 billion.

[Consolidated Earnings, KRW billion]

Q1’25

Q1’24

YoY Change

Revenue

1,298.3

946.9

351.4

Operating Profit

486.7

221.3

265.4

EBITDA

650.1

364.7

285.4

BUSINESS UPDATES

Samsung Biologics continues to secure new CDMO contracts, signing a deal worth USD 1.4 billion with a Europe-based pharmaceutical company in January, followed by additional contracts in April. The expanded partnerships reflect the company’s capability to delivering consistent quality and clients’ trust in Samsung Biologics’ services.

Plant 5 commenced operations as committed in April this year. The new plant incorporates advanced technologies and digitalized features, including an integrated manufacturing execution system, to further enhance operational efficiency and quality excellence. 

Plans to build a sixth plant in response to growing biomanufacturing demand are currently awaiting board approval. Samsung Biologics’ ADC facility also commenced operations earlier this year, further building on the company’s capability to support diverse modalities.

For the CDO business, growth was supported by upgrading technology platforms as well as enhancing service quality. Samsung Biologics signed an agreement to carry out multiple ADC projects for LigaChem Biosciences. The company also continues to support the growth of emerging biotechs through the Samsung Life Science Fund, with its latest investment being made in C2N Diagnostics, a US-based biotech firm developing blood-based diagnostics for early detection of Alzheimer’s disease.

In line with Samsung Biologics’ geographic expansion strategy to better support a broader client base and strengthen its regional presence, the company opened a sales office in Japan this year.

Samsung Biologics remains committed to sustainable and responsible growth. The company was given a ‘Low Risk’ rating and selected as an ‘Industry Top Rated’ company by Sustainalytics, and received leadership status for water security from the Carbon Disclosure Project. As a member of the Sustainable Markets Initiative’s Health Systems Task Force, the company also continues to contribute to the decarbonization of healthcare supply chains in partnership with stakeholders across the public and private sectors.

About Samsung Biologics Co., Ltd.

Samsung Biologics (KRX: 207940.KS) is a fully integrated, end-to-end CDMO service provider, offering seamless development and manufacturing services from cell line development to final aseptic fill/finish as well as laboratory testing support for the biopharmaceutical products we manufacture. Our state-of-the-art facilities are CGMP compliant with bioreactors ranging from small to large scales to serve varying client needs. Samsung Biologics offers a combined 604 kL capacity at Bio Campus I. The company launched Bio Campus II with the completion of Plant 5 in April 2025, adding 180 kL capacity. Additionally, Samsung Biologics America enables the company to work in closer proximity to clients based in the U.S. and Europe. We continue to maximize operational efficiency and upgrade our capabilities to better accommodate client needs, investing in an ADC facility, mRNA technologies, and additional aseptic filling capacity. As a sustainable CDMO partner of choice, we are committed to on-time, in-full delivery of the products we manufacture with our flexible manufacturing services, operational excellence, and proven expertise.

Samsung Biologics Media Contact

Claire Kim, Head of Marketing & Global Communications
cair.kim@samsung.com 

Hong Kong ICT Awards 2025 opens for enrolment

HONG KONG, April 23, 2025 /PRNewswire/ — The Hong Kong ICT Awards (HKICTA) 2025 opens for enrolment on April 22. Entries of locally developed information and communications technology (ICT) products and solutions are invited to compete for the Grand Awards in the eight award categories and the top accolade of the competition – the Award of the Year. Enrolment is free of charge and the deadline is July 14, 2025.

Hong Kong ICT Awards 2025 opens for enrolment
Hong Kong ICT Awards 2025 opens for enrolment

The HKICTA 2025 is organised by the Digital Policy Office (DPO) with each award category to be led by a local industry association or professional body. The award categories and respective leading organisers are listed below:

Award categories

Leading Organisers

Digital Entertainment Award

Hong Kong Digital Entertainment Association

FinTech Award

Institute of Financial Technologists of Asia

ICT Startup Award

Hong Kong Wireless Technology Industry Association

Smart Business Award

Hong Kong Computer Society

Smart Living Award

Hong Kong Information Technology Federation

Smart Mobility Award

GS1 Hong Kong

Smart People Award

The Hong Kong Council of Social Service

Student Innovation Award

Hong Kong Education City

 

A Grand Award will be granted in each category, and the Award of the Year will be selected by a Grand Judging Panel from the eight Grand Awardees.

In a bid to foster the innovative use of AI, the Best Use of AI award winner will be selected in each of the eight categories to magnify and honour outstanding achievements in harnessing the power of AI in respective areas.

Established in 2006, the HKICTA is an annual signature event of the local ICT industry which aims to recognise and promote outstanding ICT inventions and applications, thereby encouraging the pursuit of innovation and excellence among Hong Kong’s ICT professionals and enterprises to develop innovative applications meeting business and social needs, use innovation and technology (I&T) to bring benefits to the community, and foster Hong Kong’s I&T and smart city development. Through concerted efforts of the ICT sector, academia and the Government, the HKICTA has always been highly regarded by the information technology industry, and the winners may also be nominated to compete in other regional and international competitions on behalf of Hong Kong and be sponsored to participate in overseas I&T exhibitions. The award acts as an encouragement and recognition to the winners, and enables their access to both Mainland and overseas markets.

Details of the HKICTA are available on the thematic website (www.hkictawards.hk). Enquiries can be made to the DPO at 3974 5224 or by emailing hkictawards@digitalpolicy.gov.hk

YCH Group Executive Chairman Dr. Robert Yap Honoured with NTUC May Day Awards 2025 – Distinguished Service (Star) Award

SINGAPORE, April 23, 2025 /PRNewswire/ — YCH Group is proud to announce that its Executive Chairman, Dr. Robert Yap, has been conferred the prestigious NTUC May Day Awards 2025 – Distinguished Service (Star) Award. This accolade recognises Dr. Yap’s decade of leadership as President of the Singapore National Employers Federation (SNEF) and his strong commitment to improving wages, supporting fair employment practices, and helping Singapore’s workforce adapt to a changing economy.

Dr. Robert Yap, Executive Chairman, YCH Group
Dr. Robert Yap, Executive Chairman, YCH Group

As President of the SNEF from 2014 to 2024, Dr. Yap worked closely with tripartite partners to tackle key workforce challenges, including an ageing workforce, job displacement, and the need for lifelong skills upgrading. His leadership was instrumental in the formation of the Tripartite Workgroup on Lower-Wage Workers, where he championed structured wage progression and the expansion of the Progressive Wage Model (PWM) to link wage growth with skills, job scope, and productivity — creating clear career pathways while safeguarding business competitiveness.

Dr. Yap recognised the invaluable contributions of mature workers and led efforts to raise the retirement and re-employment age, setting a national roadmap towards age 70 by 2030. To support this transition, he advocated for the Senior Employment Credit (SEC), which offsets wage costs for hiring senior Singaporeans and reinforces the value of older workers in the economy.

Dr. Yap also co-led the Joint NTUC-SNEF PME Taskforce, contributing to the development of structured policies that support skills upgrading, career mobility, and fair employment practices for Professionals, Managers, and Executives (PMEs). Through various tripartite councils and workgroups, he has been a consistent voice for PME resilience amid evolving market demands. A champion of lifelong learning and upskilling, Dr. Yap strongly supported the formation of Company Training Committees (CTCs), embedding a culture of continuous learning in organisations and ensuring businesses invest in future-ready talent.

In parallel, he has been a firm believer in technology as a workforce enabler. Under his leadership, autonomous mobile robots were deployed in warehouse and retail settings to reduce physical strain on older workers, allowing them to focus on higher-value tasks. This initiative exemplified how inclusive workforce policies and automation can go hand-in-hand to support productivity while preserving employability.

Beyond national-level contributions, Dr. Yap is a visionary leader in the logistics sector, where he continues to foster strong partnerships between businesses, unions, and government agencies. Under his leadership, YCH Group has led multiple industry-transforming initiatives, equipping workers with future-ready skills while championing inclusive and sustainable growth.

“I am honoured to receive the NTUC May Day Distinguished Service (Star) Award. This recognition reflects the shared commitment of many who believe in strengthening our workforce through inclusive practices, continuous learning, and responsible leadership. As we navigate disruption and demographic shifts, I remain convinced that strong tripartite collaboration is key to building a resilient and forward-looking workforce,” said Dr. Yap.

The NTUC May Day Awards honour individuals and organisations that have made a lasting impact on the lives of workers and contributed meaningfully to Singapore’s economic and social progress. Dr. Yap’s award is a recognition of his leadership as President of SNEF and highlights the strength of tripartite cooperation in advancing a fairer and more resilient workforce.

YCH Group congratulates Dr. Yap on this well-deserved accolade and reaffirms its commitment to fostering an inclusive workplace that empowers employees and supports the continued transformation of the logistics sector.

About YCH Group

YCH Group is Singapore’s leading homegrown end-to-end supply chain solutions provider, with a presence in over 100 cities across the Asia Pacific. YCH focuses on boosting productivity and sustainability for its customers with its proprietary best-in-class suite of award-winning solutions across industries such as fast-moving consumer goods, electronics, chemical and healthcare, cold chain logistics, and e-Commerce. A strong proponent of innovation, YCH is recognised for its 7PL™ approach in seamlessly integrating supply chain strategy with execution. Its leadership in initiatives like the ASEAN Smart Logistics Network (ASLN) underscores its pivotal role in advancing the goals of regional frameworks and multilateral trade agreements, such as the ASEAN Economic Community (AEC), the Regional Comprehensive Economic Partnership (RCEP), and the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP).

Sinopec Makes Overseas Debut with Global Energy Forecast: Global Energy Outlook 2060 Report Released

The Company Consolidates Common Goals and Business Cooperation in Energy Transformation with Three Published Research Reports in Energy and Chemicals

RIYADH, Saudi Arabia, April 23, 2025 /PRNewswire/ — China Petroleum & Chemical Corporation (HKG: 0386, “Sinopec”) officially released the first Global Energy Outlook 2060 report (the “Report”) on April 21 at the overseas launch event for China’s energy and chemical industry reports held in Riyadh, Saudi Arabia. Two more reports, the China Energy Outlook 2060 (2025 Edition) and the 2025 China Energy and Chemical Industry Outlook, were published at the event as well.

This is Sinopec’s third overseas release event in Saudi Arabia, strengthening collaboration on energy transition and promoting academic and business exchanges.

Sinopec Makes Overseas Debut with Global Energy Forecast: Global Energy Outlook 2060 Report Released.
Sinopec Makes Overseas Debut with Global Energy Forecast: Global Energy Outlook 2060 Report Released.

The Report marks the first time a Chinese enterprise has published a mid- to long-term global energy outlook overseas, using innovative research for improved forecasts. It predicts global primary energy consumption will peak at 26.71 billion tonnes of standard coal by 2045, with renewables comprising 51.8% by 2060. Energy consumption will slow to 25.25 billion tonnes by 2060, with oil and gas making up 35.7%.

Oil consumption will peak at 4.66 billion tonnes in 2030, shifting focus from transportation to industrial raw materials, while still accounting for 40% of transportation energy by 2060.

Non-fossil energy will see major growth: hydrogen use will rise from 2% in 2023 to nearly 50% by 2060, exceeding 340 million tonnes annually. CCUS capacity will expand to 110 million tonnes by 2030 and 4.7 billion tonnes by 2060, driving the energy transition.

The China Energy Outlook 2060 (2025 Edition) predicts China’s primary energy use will plateau after 2030, peaking at 6.8–7.1 billion tonnes of standard coal. Oil demand will peak before 2027, while non-fossil energy will surpass fossil fuels in power generation by 2035. CO₂ emissions from energy are expected to peak at 10.8–11.2 billion tonnes before 2030, ensuring an early carbon peak.

The 2025 China Energy and Chemical Industry Outlook notes that China’s total refining capacity will peak at 960–970 million tonnes per year by 2025, while the chemical industry faces overcapacity in olefins, aromatics, a sustained high capacity levels of bulk chemical products.

For more insightful details of the reports, please visit http://www.sinopec.com/listco/en/.